OpenVigil FDA – Inspection of U.S. American Adverse Drug Events Pharmacovigilance Data and Novel Clinical Applications

• Ruwen Böhm ,

  * E-mail: ruwen.boehm@pharmakologie.uni-kiel.de

  Affiliation Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany

  ⨯
• Leocadie von Hehn,

  Affiliation Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany

  ⨯
• Thomas Herdegen,

  Affiliation Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany

  ⨯
• Hans-Joachim Klein,

  Affiliation Department of Computer Science, Christian-Albrechts University, Kiel, Germany

  ⨯
• Oliver Bruhn,

  Affiliation Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany

  ⨯
• Holger Petri,

  Affiliation Hospital pharmacy, Wicker Kliniken, Bad Wildungen-Reinhardshausen, Germany

  ⨯
• Jan Höcker

  Affiliation Department of Anaesthesiology and Intensive Care Medicine, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany

  ⨯